Skip to main content

Articles

Pulmonary Inflammation Home Visit Case Study in Australia

18 Nov 2021

This case study reviews Labcorp MCS support of a global pulmonary inflammation clinical trial that was active in Australia, highlighting the benefits on a global level and the specific challenges faced in the Pacific country.